# Ayaangwaamiziwin Initiative: Carefulness and Preparedness

> **NCT06893159** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Unity Health Toronto** · enrollment: 10000 (estimated)

## Conditions studied

- Point-of-Care Testing
- HIV
- Syphilis

## Interventions

- **DEVICE:** INSTI HIV-1/2 Antibody Test
- **DEVICE:** INSTI Multiplex HIV-1/2 Syphilis Antibody Test
- **DEVICE:** Multiplo Complete Syphilis (TP/nTP) Antibody Test

## Key facts

- **NCT ID:** NCT06893159
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-03
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06893159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06893159, "Ayaangwaamiziwin Initiative: Carefulness and Preparedness". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06893159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*